No definition available.
Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)
C3_OVARY_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
2437 |
4. Check minimum number of eventsNone |
2437 |
5. Include endpointsNone |
2437 |
6. Filter based on genotype QC (FinnGen only) |
2437 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2437 | 2437 | - |
| Unadjusted period prevalence (%) | 0.83 | 0.83 | - |
| Median age at first event (years) | 61.41 | 61.41 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1496
- Matched controls
- 14959
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
323.0
818
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
323.0
414
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
323.0
312
*
A04AA01
ATC
ondansetron; systemic, rectal
56.9
323.0
613
180
128
Kela drug reimbursment
Cancers of female genital organs
+∞
323.0
877
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
323.0
395
*
JAL30
NOMESCO Finland
Omentectomy
401.5
323.0
506
19
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
6870.6
323.0
486
*
A03FA01
ATC
metoclopramide; systemic, rectal
19.9
323.0
963
1245
H02AB02
ATC
dexamethasone; systemic
186.6
323.0
740
78
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
+∞
323.0
431
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2071.3
323.0
319
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
43.1
323.0
490
167
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
323.0
405
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3914.7
323.0
323
*
JN4BD
NOMESCO Finland
Extensive body CT
25.2
323.0
510
301
B01AB10
ATC
tinzaparin; parenteral
22.9
323.0
495
316
WX302
NOMESCO Finland
Thoracal epidural anesthesy
38.6
307.4
395
138
JEA00
NOMESCO Finland
Appendectomy
20.7
305.4
478
331
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
28.5
279.1
389
182
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
21.6
276.7
424
269
8441/3-C56.9
ICD-O-3
Serous carcinoma, NOS, of ovary
+∞
246.9
230
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
23.2
241.6
359
201
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
13.9
229.4
423
413
Z51.5
ICD-10 Finland
Palliative care
41.3
226.9
286
85
R18
ICD-10 Finland
Ascites
71.9
212.8
242
40
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
212.7
199
*
A04AA02
ATC
granisetron; systemic, transdermal
467.9
208.9
204
5
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
208.3
195
*
A04AA55
ATC
palonosetron, combinations; systemic
2123.4
208.2
197
*
L02BG04
ATC
letrozole; oral
76.6
202.2
228
35
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
200.6
188
*
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
+∞
190.8
179
*
L03AA02
ATC
filgrastim; parenteral
657.3
180.6
175
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
176.6
166
*
JAL00
NOMESCO Finland
Biopsy of peritoneum
201.8
174.0
178
10
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
1908.3
172.3
164
*
JN4AD
NOMESCO Finland
Body CT examination
18.3
171.8
276
183
B01AB05
ATC
enoxaparin; parenteral
4.9
171.4
818
2975
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
169.0
159
*
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
167.9
158
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.7
167.7
864
3373
LCD00
NOMESCO Finland
Hysterectomy
9.5
165.9
373
507
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
830.8
155.3
150
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
142.0
134
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
1457.4
138.8
133
*
WW500
NOMESCO Finland
Blood transfusion
23.4
136.7
200
98
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
6.0
135.9
430
937
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
134.4
127
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
131.2
124
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
20.6
124.1
189
104
N02AA05
ATC
oxycodone; systemic
5.6
122.0
408
936
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
63.2
118.7
138
24
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
97.4
114.0
125
14
ZX120
NOMESCO Finland
Intravenous
7.4
112.9
293
477
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.7
108.0
653
2611
TPH07
NOMESCO Finland
Cathetrisation of artery
6.3
104.9
307
586
8310/3-C56.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of ovary
+∞
102.3
97
*
C56.92
ICD-10 Finland
Malignant ovarian tumor, sex chord stroma derived
+∞
102.3
97
*
JAH01
NOMESCO Finland
Laparoscopy
9.3
102.0
224
277
8620/3-C56.9
ICD-O-3
Adult granulosa cell tumor of ovary of ovary
+∞
101.2
96
*
115
Kela drug reimbursment
Breast cancer
+∞
101.2
96
*
X77
ICPC
Malignant neopl genital female other
+∞
101.2
96
*
130
Kela drug reimbursment
Malignant tumour
+∞
101.2
96
*
C56.74
ICD-10 Finland
Mesonephroid epithelial carcinoma of the ovary
+∞
101.2
96
*
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
161.1
100.5
105
7
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
100.1
95
*
L02BA01
ATC
tamoxifen; oral
521.4
99.7
98
*
8470/3-C56.9
ICD-O-3
Mucinous cystadenocarcinoma, NOS, of ovary
+∞
99.1
94
*
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
96.9
92
*
JAH00
NOMESCO Finland
Laparotomy
17.0
95.2
155
101
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
94.8
90
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
93.7
89
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
79.5
92.6
104
14
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
91.6
87
*
A04AA03
ATC
tropisetron; systemic
+∞
90.5
86
*
8460/3-C56.9
ICD-O-3
Low grade serous carcinoma of ovary
+∞
90.5
86
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
90.5
86
*
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
88.4
84
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
12.4
85.2
159
142
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.9
83.5
306
745
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
+∞
81.0
77
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
11.7
80.4
154
145
PJA12
NOMESCO Finland
Sentinel node biopsy
413.8
79.7
79
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
77.8
74
*
JAL31
NOMESCO Finland
Laparoscopic omentectomy
105.6
73.7
80
8
Z31.5
ICD-10 Finland
Genetic counselling
8.5
72.7
167
218
TPX10
NOMESCO Finland
Implantation of vascular injection port
15.8
72.5
121
83
WX402
NOMESCO Finland
General anaesthesia
3.9
71.8
339
1040
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
71.4
68
*
HA1AA
NOMESCO Finland
X-ray mammography
7.3
71.2
182
280
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
363.7
70.2
70
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
112.7
69.5
75
7
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
69.3
66
*
3009
Kela drug reimbursment
Niraparib
+∞
69.3
66
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.3
69.1
436
1680
C56.91
ICD-10 Finland
Malignant granulosa cell tumor in ovary
+∞
68.2
65
*
1510
Kela drug reimbursment
Niraparib
+∞
67.2
64
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
677.2
66.5
65
*
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
20.9
65.3
98
50
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
3.5
64.6
351
1198
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.0
63.8
151
206
TJA10
NOMESCO Finland
Laparocentesis
331.8
62.9
63
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
219.0
61.6
63
*
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
30.8
59.1
79
27
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
58.7
56
*
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
25.4
58.2
82
34
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
57.7
55
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
9.0
57.3
126
152
1XC07
NOMESCO Finland
NA
+∞
56.6
54
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
55.6
53
*
L01XK02
ATC
niraparib; oral
+∞
55.6
53
*
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
+∞
55.6
53
*
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.5
55.3
301
1017
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
90.8
55.3
61
7
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
54.5
52
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
52.4
50
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
14.0
51.7
90
68
D70.82
ICD-10 Finland
Drug-induced neutropenia
39.3
50.7
64
17
A04AD12
ATC
aprepitant; systemic
+∞
50.3
48
*
8480/3-C56.9
ICD-O-3
Mucinous adenocarcinoma of ovary
+∞
50.3
48
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
14.1
47.9
83
62
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
482.6
47.6
47
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
52.8
47.1
56
11
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
9.7
46.1
96
105
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
9.7
46.1
96
105
D39.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified
44.6
45.7
56
13
XX3DW
NOMESCO Finland
Time consuming IT work
5.1
45.6
152
323
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
17.1
45.1
72
44
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
+∞
45.0
43
*
HAC20
NOMESCO Finland
Total mastectomy
158.1
44.0
46
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
+∞
44.0
42
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
45.7
43.4
53
12
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
440.0
43.4
43
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.2
43.2
175
454
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
42.9
41
*
C567
ICD-10 Finland
NA
+∞
42.9
41
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
37.3
42.5
54
15
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
41.9
40
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
6.9
41.4
107
165
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
215.9
41.1
42
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
25.2
39.9
56
23
HAB40
NOMESCO Finland
Wedge excision of mammary gland
18.7
39.5
61
34
A79
ICPC
Malignancy NOS
140.4
38.9
41
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
38.7
37
*
JBA10
NOMESCO Finland
Transabdominal biopsy or excision of lesion of diaphragm
+∞
38.7
37
*
ZXC40
NOMESCO Finland
Use of ultrasound
23.3
37.7
54
24
C50.99
ICD-10 Finland
Breast, unspecified
+∞
37.7
36
*
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
+∞
37.7
36
*
WF004
NOMESCO Finland
Palliative radiotherapy
376.4
37.2
37
*
JFB46
NOMESCO Finland
Resection of sigmoid colon
13.5
37.1
65
50
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
36.6
35
*
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
9.2
36.6
78
89
WZC30
NOMESCO Finland
Teaching
3.2
35.3
202
692
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
35.3
239
920
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.1
34.9
114
236
JFB00
NOMESCO Finland
Partial resection of small intestine
11.9
34.5
64
56
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
34.8
34.2
44
13
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
24.7
34.2
48
20
JN4CD
NOMESCO Finland
Very extensive body CT
8.9
33.6
73
86
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
33.5
32
*
JFF10
NOMESCO Finland
Loop enterostomy
57.1
33.4
39
7
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
33.2
236
933
A06AH03
ATC
naloxegol; oral
41.1
32.2
40
10
J94.8
ICD-10 Finland
Other specified pleural conditions
12.6
31.6
57
47
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
31.4
30
*
1511
Kela drug reimbursment
Olaparib
+∞
31.4
30
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
31.4
30
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
31.4
30
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
12.3
31.3
57
48
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
27.0
30.7
42
16
389
Kela drug reimbursment
Olaparib
+∞
30.3
29
*
8102
FHL
Second look"" surgery for a malignant tumor
308.4
29.9
30
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
26.3
29.8
41
16
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
7.8
29.5
69
92
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.7
29.3
134
384
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
29.3
28
*
8000/3-C56.9
ICD-O-3
Neoplasm, malignant of ovary
+∞
29.3
28
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
5.8
29.0
85
155
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
28.6
393
2163
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
28.2
27
*
L01CB01
ATC
etoposide; systemic
+∞
28.2
27
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
28.1
656
4414
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
27.9
149
483
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
27.2
26
*
1XA02
NOMESCO Finland
NA
+∞
27.2
26
*
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
3.4
26.9
139
440
R50.9
ICD-10 Finland
Fever, unspecified
2.6
26.8
209
866
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
98.6
26.7
29
*
L01BC06
ATC
capecitabine; oral
+∞
26.1
25
*
L01XK01
ATC
olaparib; oral
+∞
26.1
25
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
8.3
26.0
58
72
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
137.4
25.7
27
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.1
25.6
104
269
A98
ICPC
Health maint/preventive medicine
0.4
25.3
1236
13712
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
25.1
24
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
25.1
24
*
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
3.7
24.9
114
327
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
9.6
24.8
51
55
L01XX54
ATC
[U] niraparib; oral
+∞
24.0
23
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
11.6
23.7
44
39
JFA70
NOMESCO Finland
Suture of small intestine
88.2
23.7
26
*
N02AX02
ATC
tramadol; systemic, rectal
1.8
23.0
647
4533
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
23.0
22
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
23.0
22
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
23.0
22
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
84.8
22.7
25
*
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
12.8
22.7
40
32
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
19.3
22.6
34
18
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
10.8
22.4
43
41
LAF01
NOMESCO Finland
Laparoscopic unilateral salpingo-oophorectomy
4.4
22.4
83
197
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
22.1
208
951
8980/3-C56.9
ICD-O-3
Carcinosarcoma, NOS, of ovary
+∞
21.9
21
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
21.9
21
*
K56.7
ICD-10 Finland
Ileus, unspecified
8.1
21.3
48
61
WF002
NOMESCO Finland
Radical radiotherapy
23.5
21.3
30
13
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
21.0
567
3887
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
20.9
20
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
20.9
20
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
20.9
20
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
20.9
20
*
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
+∞
20.9
20
*
9080/3-C56.9
ICD-O-3
Teratoma, malignant, NOS, of ovary
+∞
20.9
20
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
20.8
150
592
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.6
20.6
96
280
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
18.6
20.4
31
17
R11
ICD-10 Finland
Nausea and vomiting
2.6
20.4
163
682
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
19.1
20.0
30
16
JFB20
NOMESCO Finland
Ileocaecal resection
19.1
20.0
30
16
JFF23
NOMESCO Finland
Transversostomy
21.1
20.0
29
14
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
14.6
19.9
33
23
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
19.8
19
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
19.8
19
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.3
19.8
102
322
XX1XW
NOMESCO Finland
Extensive written report from radiologist
6.3
19.2
51
83
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.0
19.1
62
129
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.9
19.0
53
92
ZX121
NOMESCO Finland
Central venous catheter
55.8
19.0
22
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
55.8
19.0
22
*
8140/3-C56.9
ICD-O-3
Adenocarcinoma, NOS, of ovary
+∞
18.8
18
*
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
+∞
18.8
18
*
LAF17
NOMESCO Finland
Laparoscopic excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
18.8
18
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
18.8
18
*
JFB53
NOMESCO Finland
Resection of sigmoid colon with partial proctectomy
101.3
18.6
20
*
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
101.3
18.6
20
*
L02BG03
ATC
anastrozole; oral
192.3
18.6
19
*
B03XA02
ATC
darbepoetin alfa; parenteral
8.5
18.5
40
48
LEB00
NOMESCO Finland
Biopsy of vagina
5.2
18.3
57
113
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
7.5
18.3
43
59
KCH00
NOMESCO Finland
Suture of bladder
27.1
17.8
24
9
JFB30
NOMESCO Finland
Right hemicolectomy
13.9
17.8
30
22
X81
ICPC
Genital neopl female other/unspecif
67.4
17.7
20
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
17.7
17
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
17.7
17
*
3AA13
NOMESCO Finland
NA
+∞
17.7
17
*
SPAT1153
SPAT
Removal of sutures
1.7
17.7
479
3247
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
9.9
17.2
34
35
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
31.9
17.1
22
7
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
50.6
17.0
20
*
A02BC02
ATC
pantoprazole; systemic
1.6
16.9
985
8142
8440/3-C56.9
ICD-O-3
Cystadenocarcinoma, NOS, of ovary
+∞
16.7
16
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
16.7
16
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
16.7
16
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
16.7
16
*
9060/3-C56.9
ICD-O-3
Dysgerminoma of ovary
+∞
16.7
16
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
16.7
16
*
8010/3-C56.9
ICD-O-3
Carcinoma, NOS, of ovary
+∞
16.7
16
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
16.7
16
*
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
35.5
16.7
21
6
Z93.3
ICD-10 Finland
Colostomy status
23.3
16.4
23
10
JAW96
NOMESCO Finland
Other operation on abdominal wall, peritoneum, mesentery or omentum
20.3
16.4
24
12
S18
ICPC
Laceration/cut
1.6
16.3
592
4323
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.7
16.3
71
197
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
15.6
15
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
15.6
15
*
L01XX46
ATC
[U] olaparib; oral
+∞
15.6
15
*
JJA40
NOMESCO Finland
Excision of lesion of liver
+∞
15.6
15
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
86.0
15.6
17
*
JFA80
NOMESCO Finland
Suture of colon
22.3
15.6
22
10
N02BE01
ATC
paracetamol; systemic, rectal
1.9
15.5
1304
11755
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
15.4
160
762
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
15.1
133
586
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.5
14.9
53
122
D69.5
ICD-10 Finland
Secondary thrombocytopenia
32.0
14.8
19
6
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
32.0
14.8
19
6
JBA20
NOMESCO Finland
Transabdominal partial excision of diaphragm
+∞
14.6
14
*
X76
ICPC
Malignant neoplasm breast female
+∞
14.6
14
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
14.6
14
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
14.6
14
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
14.6
14
*
1CD02
NOMESCO Finland
NA
+∞
14.6
14
*
XW2AT
NOMESCO Finland
Cytology of deep organ with ultrasound quidance
+∞
14.6
14
*
8205
FHL
Subradical ovarian malignancy removal (includes possible genital and omet removal)
80.9
14.6
16
*
JAL96
NOMESCO Finland
Other excision of lesion of peritoneum
80.9
14.6
16
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
80.9
14.6
16
*
ZX080
NOMESCO Finland
Image guided radiotherapy
151.4
14.5
15
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
151.4
14.5
15
*
ZX112
NOMESCO Finland
Subcutaneous
9.5
14.5
29
31
KBV10
NOMESCO Finland
Removal of stent from ureter
12.7
14.4
25
20
TJF80
NOMESCO Finland
Ostomy education
17.2
14.3
22
13
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
7.8
14.2
32
42
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
53.9
13.8
16
*
D27.99
ICD-10 Finland
Benign tumor of the ovary (ovary), unspecified histology
8.7
13.8
29
34
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
4.4
13.6
49
115
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
13.6
13
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
13.6
13
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
13.6
13
*
TPX15
NOMESCO Finland
Removal of vascular injection port
34.4
13.5
17
5
K56.0
ICD-10 Finland
Paralytic ileus
9.5
13.5
27
29
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
141.2
13.5
14
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
21.4
13.3
19
9
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.9
13.1
195
1078
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
15.2
13.1
21
14
Z51.88
ICD-10 Finland
Other specified medical care
4.8
13.1
43
92
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
16.9
13.0
20
12
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
50.4
12.9
15
*
JBA00
NOMESCO Finland
Transabdominal repair of diaphragm for rupture
70.5
12.6
14
*
C50
ICD-10 Finland
Malignant neoplasm of breast
70.5
12.6
14
*
LCD30
NOMESCO Finland
Radical hysterectomy
70.5
12.6
14
*
R4190
NOMESCO Finland
Nutritional therapy
3.9
12.6
51
134
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
12.5
12
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
12.5
12
*
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
7.4
12.5
29
40
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
14.5
12.3
20
14
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
12.5
12.1
21
17
LWA00
NOMESCO Finland
Repair of wound dehiscence in gynaecological surgery
26.9
12.1
16
6
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
12.0
126
604
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.0
12.0
69
238
LWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gynaecological surgery
47.0
11.9
14
*
SAA01
NOMESCO Finland
Simple examination of mouth
0.7
11.8
705
8479
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
8.7
11.5
24
28
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
11.5
119
564
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
11.5
11
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
11.5
11
*
WC401
NOMESCO Finland
Simple antibody therapy of local recurrence of tumour
+∞
11.5
11
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
C48.19
ICD-10 Finland
Malignant tumor in specified location in peritoneum other or unspecified histlogy
+∞
11.5
11
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
11.5
11
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
11.5
11
*
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
120.9
11.4
12
*
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.8
11.3
47
127
B01AB04
ATC
dalteparin; parenteral
2.6
11.1
82
331
JFF30
NOMESCO Finland
Other colostomy
43.6
10.9
13
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
43.6
10.9
13
*
SAA02
NOMESCO Finland
Basic examination of mouth
0.7
10.9
607
7439
R03AC02
ATC
salbutamol; inhalant
0.7
10.8
517
6518
R2110
NOMESCO Finland
Giving the first information
2.1
10.8
120
590
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
60.4
10.6
12
*
Z51.0
ICD-10 Finland
Radiotherapy session
60.4
10.6
12
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
60.4
10.6
12
*
SPAT1109
SPAT
Analgesia with portable analgesic pump
14.3
10.5
17
12
JN3DM
NOMESCO Finland
Abdominal very extensive MRI examination with 3 Tesla magnet
110.8
10.4
11
*
C48.20
ICD-10 Finland
Malignant tumor in unspecified localization in the peritoneum without histology
+∞
10.4
10
*
HAC25
NOMESCO Finland
Radical mastectomy
+∞
10.4
10
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
10.4
10
*
9110/3-C56.9
ICD-O-3
Mesonephroma, malignant of ovary
+∞
10.4
10
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
10.4
10
*
8461/3-C57.0
ICD-O-3
High grade serous carcinoma of fallopian tube
+∞
10.4
10
*
9071/3-C56.9
ICD-O-3
Yolk sac tumor, NOS, of ovary
+∞
10.4
10
*
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
10.4
10
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.9
10.4
25
37
JFF13
NOMESCO Finland
Terminal enterostomy
32.8
10.3
13
*
JFB50
NOMESCO Finland
Other resection of colon
32.8
10.3
13
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
10.7
10.3
19
18
ZXC96
NOMESCO Finland
Robot assisted procedure
6.7
10.2
25
38
B03XA01
ATC
erythropoietin; parenteral
13.2
10.2
17
13
JFB40
NOMESCO Finland
Resection of transverse colon
40.3
10.0
12
*
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
16.8
9.9
15
9
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
26.2
9.8
13
5
TLE30
NOMESCO Finland
Tamponation of vagina
13.5
9.7
16
12
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
4.0
9.6
37
94
TGA30
NOMESCO Finland
Thoracocentesis
11.4
9.6
17
15
KA1FN
NOMESCO Finland
Isotope renography
11.4
9.6
17
15
M01AH05
ATC
etoricoxib; oral
0.7
9.5
599
7266
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
15.1
9.5
15
10
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
3.7
9.4
40
111
RS220
NOMESCO Finland
NA
5.2
9.4
28
55
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
+∞
9.4
9
*
1DB01
NOMESCO Finland
NA
+∞
9.4
9
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
9.4
9
*
1CD01
NOMESCO Finland
NA
+∞
9.4
9
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
9.4
9
*
5703
FHL
Removal of lymph nodes from the retroperitoneal space
+∞
9.4
9
*
C574, 8461, 3
ICD-O-3
NA
+∞
9.4
9
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
9.4
9
*
C76.3
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Pelvis
+∞
9.4
9
*
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
3.7
9.3
39
107
JFB43
NOMESCO Finland
Left hemicolectomy
10.7
9.3
17
16
LCA06
NOMESCO Finland
Biopsy of endometrium
1.7
9.3
223
1430
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
15.7
9.0
14
9
SPAT1125
SPAT
Stoma care and guidance
4.2
8.9
32
77
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.3
8.9
42
128
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
8.8
251
1682
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
10.8
8.8
16
15
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
7.2
8.7
20
28
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.0
8.7
115
608
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
14.1
8.7
14
10
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
50.3
8.7
10
*
TQW20
NOMESCO Finland
Tatoe
50.3
8.7
10
*
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
0.5
8.6
63
1241
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
27.7
8.5
11
*
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
20.1
8.5
12
6
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
20.1
8.5
12
6
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
90.6
8.4
9
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
8.3
8
*
C78.5
ICD-10 Finland
Secondary malignant neoplasm of large intestine and rectum
+∞
8.3
8
*
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
+∞
8.3
8
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
8.3
8
*
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
+∞
8.3
8
*
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
8.3
8
*
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
+∞
8.3
8
*
GAE03
NOMESCO Finland
Suture of chest wall
+∞
8.3
8
*
C57.7
ICD-10 Finland
Malignant neoplasm: Other specified female genital organs
+∞
8.3
8
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
8.3
8
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
8.3
8
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
8.3
8
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
8.3
8
*
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
+∞
8.3
8
*
C79.6
ICD-10 Finland
Secondary malignant neoplasm of ovary
+∞
8.3
8
*
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
4.6
8.3
27
59
Z93.2
ICD-10 Finland
Ileostomy status
10.8
8.3
15
14
N02AA01
ATC
morphine; systemic, rectal
7.1
8.3
19
27
D70.89
ICD-10 Finland
Neutropenic splenomegaly
6.1
8.2
21
35
GD1AD
NOMESCO Finland
Thorax CT examination
2.9
8.1
47
165
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
8.2
8.1
17
21
J91
ICD-10 Finland
Pleural effusion in conditions classified elsewhere
33.5
8.1
10
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
17.3
8.1
12
7
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.5
8.0
58
233
WX892
NOMESCO Finland
Monitored bed care
2.0
7.9
94
477
A06AD11
ATC
lactulose; oral
1.6
7.9
205
1339
JN6AD
NOMESCO Finland
CT of torso and neck
13.1
7.9
13
10
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
45.2
7.7
9
*
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
45.2
7.7
9
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
45.2
7.7
9
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.7
7.7
255
3481
D27.98
ICD-10 Finland
Benign tumor of the ovary (ovary), other specified histology
7.5
7.7
17
23
C10AA07
ATC
rosuvastatin; oral
0.6
7.6
180
2624
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
5.2
7.6
22
43
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
6.2
7.5
19
31
WX320
NOMESCO Finland
Spinalanesthesy
0.6
7.5
165
2441
G03AC03
ATC
levonorgestrel; systemic
0.5
7.5
79
1395
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
80.5
7.4
8
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
80.5
7.4
8
*
LCC10
NOMESCO Finland
Supravaginal hysterectomy
5.3
7.4
21
40
N13.1
ICD-10 Finland
Hydronephrosis with ureteral stricture, not elsewhere classified
13.4
7.4
12
9
T81.2
ICD-10 Finland
Accidental puncture and laceration during a procedure, not elsewhere classified
4.2
7.3
26
63
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
10.9
7.3
13
12
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
7.3
7
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
7.3
7
*
L02BG06
ATC
exemestane; oral
+∞
7.3
7
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
+∞
7.3
7
*
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
+∞
7.3
7
*
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
+∞
7.3
7
*
C54.23
ICD-10 Finland
Carcinosarcoma
+∞
7.3
7
*
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
+∞
7.3
7
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
7.3
7
*
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
7.3
7
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.3
7
*
C48.10
ICD-10 Finland
Malignant tumor in specified location in the peritoneum without histology
+∞
7.3
7
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
7.3
7
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
7.3
7
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
7.3
7
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
7.3
7
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
7.3
7
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
9.4
7.3
14
15
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
0.4
7.3
31
737
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
4.0
7.2
27
69
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
20.1
7.1
10
5
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
5.1
7.1
21
42
G56.0
ICD-10 Finland
Carpal tunnel syndrome
0.6
7.1
95
1574
WX600
NOMESCO Finland
Single shot through catheter
4.7
7.0
22
47
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.8
6.8
21
44
KA3EB
NOMESCO Finland
Antegrade pyelography
11.0
6.8
12
11
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
16.8
6.7
10
6
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.7
6.7
521
6248
L15
ICPC
Knee symptom/complaint
0.7
6.7
184
2612
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.7
6.7
182
2586
G47.3
ICD-10 Finland
Sleep apnoea
0.6
6.6
96
1561
LAE11
NOMESCO Finland
Unilateral laparoscopic oophorectomy
4.8
6.5
20
42
N05CF01
ATC
zopiclone; oral
1.4
6.5
467
3750
JGB10
NOMESCO Finland
Partial proctectomy and end colostomy
70.1
6.4
7
*
JFC10
NOMESCO Finland
Ileotransversostomy
70.1
6.4
7
*
JGA60
NOMESCO Finland
Suture of rectum
70.1
6.4
7
*
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
70.1
6.4
7
*
C03CA01
ATC
furosemide; systemic
1.4
6.4
379
2940
J01DB01
ATC
cefalexin; oral
1.4
6.4
1124
10302
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.3
6.4
30
93
M54.5
ICD-10 Finland
Low back pain
0.7
6.3
283
3685
ZZR10
NOMESCO Finland
Flap of skin and muscle
18.1
6.3
9
5
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
+∞
6.3
6
*
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
+∞
6.3
6
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
L02BA03
ATC
fulvestrant; parenteral
+∞
6.3
6
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
6.3
6
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
+∞
6.3
6
*
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
+∞
6.3
6
*
JAL23
NOMESCO Finland
Excision of local lesion of pelvic wall
+∞
6.3
6
*
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
JN4DD
NOMESCO Finland
Scout CT scan of torso
+∞
6.3
6
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
6.3
6
*
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
0.7
6.3
341
4312
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
26.8
6.2
8
*
D82
ICPC
Teeth/gum disease
0.7
6.2
265
3483
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.7
6.2
410
5039
WX704
NOMESCO Finland
Intubation
1.9
6.1
84
451
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
12.6
6.1
10
8
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
10.1
6.0
11
11
M79.6
ICD-10 Finland
Pain in limb
0.7
6.0
355
4440
R01AD12
ATC
fluticasone furoate; nasal
0.7
6.0
228
3057
G02BA03
ATC
plastic IUD with progestogen
0.5
6.0
49
930
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
732
582
17.55
307.65
1.4
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
972
527
30.02
307.65
1.8
1.4
pmol/l
453.3
74.5
24.16
934
512
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1058
1120
15.93
307.65
2.4
1.4
ug/l
6.9
14.0
0.29
773
832
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
252
31
90.55
307.65
5.8
1.4
ng/l
123.3
66.1
—
118
10
(4281824)
680
155
60.46
307.65
1.3
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
1697
1161
45.84
307.65
14.6
1.5
u/ml
146.0
25.5
15.26
1670
1102
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
334
408
9.33
259.41
2.5
1.8
u/ml
115.5
88.9
0.18
282
325
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
196
117
18.13
238.63
4.5
1.2
ug/l
20.9
2.8
1.91
103
98
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
149
46
34.44
233.73
2.3
1.0
u/ml
61.4
16.2
5.14
141
39
(3012095) Magnesium [Moles/volume] in Serum or Plasma
837
2738
4.13
223.48
6.5
2.3
mmol/l
0.8
0.8
18.46
809
2483
(3024561) Albumin [Mass/volume] in Serum or Plasma
1634
8419
3.86
218.14
6.3
3.5
g/l
32.8
36.0
69.44
1579
7644
(3044640) Blood type and Crossmatch panel - Blood
1247
5576
3.53
204.16
2.9
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1627
8621
3.67
201.99
5.1
3.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
168
103
17.44
201.49
1.1
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1009
4255
3.34
175.99
2.9
1.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
596
1847
3.95
166.54
6.3
6.2
mmol/l
0.7
1.5
5.93
503
1428
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1669
9649
3.32
165.90
10.6
3.5
umol/l
9.0
10.4
6.17
1617
8925
(3023368) Bacteria identified in Blood by Culture
991
4277
3.22
164.00
4.2
3.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
593
1862
3.89
162.23
6.4
6.2
kpa
15.9
12.0
33.38
573
1764
(40768806) Pleura Pathology biopsy report
127
68
19.65
162.12
1.3
1.5
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
593
1864
3.88
161.95
6.4
6.2
kpa
5.1
5.1
0.15
573
1772
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
198
244
8.74
151.11
2.1
2.0
u/ml
350.3
62.3
1.04
181
222
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
252
416
6.64
148.32
1.8
2.4
g/l
3.8
3.5
1.71
244
394
(3023487) Leukocytes [#/volume] in Peritoneal fluid
98
37
27.55
143.59
1.3
3.1
e6/l
8717.9
890.9
0.71
59
27
(3013650) Neutrophils [#/volume] in Blood by Automated count
1746
10900
3.12
141.15
22.2
6.5
e9/l
3.7
4.1
10.32
1531
9308
(3002173) Hemoglobin [Mass/volume] in Arterial blood
495
1502
3.88
140.74
6.5
6.9
g/l
113.2
119.8
13.22
481
1433
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
467
1410
3.86
133.25
1.8
2.1
g/l
0.2
0.2
2.47
440
1287
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
85
34
25.87
121.88
1.3
2.4
e6/l
11230.2
107411.3
0.70
40
15
(3043409) Potassium [Moles/volume] in Arterial blood
243
508
5.20
110.71
5.1
3.8
mmol/l
3.8
3.8
0.03
237
483
(3044007) Cell count panel - Peritoneal fluid
78
33
24.38
109.46
1.4
2.9
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
924
4596
2.63
108.03
4.8
3.1
%
95.3
94.1
0.86
906
4448
(3019060) Gas panel - Arterial blood
368
1101
3.76
105.01
4.9
4.8
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
363
1081
3.77
104.26
8.0
6.6
mmol/l
24.6
25.0
1.47
349
988
(3033799) Differential panel - Peritoneal fluid
75
33
23.42
103.63
1.3
2.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1280
7568
2.46
101.50
2.6
1.7
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
228
488
5.05
100.88
1.8
2.0
%
89.4
94.8
2.37
222
445
(3018405) Lactate [Moles/volume] in Arterial blood
251
583
4.68
100.65
5.0
3.6
mmol/l
1.3
1.4
0.33
251
569
(3003434) Protein [Mass/volume] in Pleural fluid
116
121
10.02
100.17
1.2
1.4
g/l
39.0
26.9
11.97
108
103
(3016502) Oxygen saturation in Arterial blood
454
1626
3.20
97.16
6.6
6.6
%
97.3
95.3
9.59
440
1553
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
325
948
3.80
95.87
7.4
7.4
%
0.8
0.7
5.62
325
942
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
325
957
3.76
94.50
7.3
7.3
%
1.5
1.4
0.78
325
951
(3023199) Leukocytes [#/volume] in Pleural fluid
108
113
9.95
93.00
1.3
1.5
e6/l
1497.3
2641.5
0.51
79
90
(3020891) Body temperature
264
692
4.16
90.28
5.7
4.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
879
4596
2.43
88.84
16.7
4.7
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
97
97
10.37
86.24
1.2
1.5
e6/l
19542.6
89520.6
0.54
56
56
(3032080) INR in Blood by Coagulation assay
1228
7554
2.26
83.33
7.4
8.6
inr
1.2
1.2
1.82
324
2178
(3000991) Gas panel - Venous blood
366
1282
3.18
80.40
7.1
6.6
—
—
—
0
0
(3002256) Pathology report gross observation
436
1691
2.92
80.05
1.3
1.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
391
1428
3.07
79.92
6.1
5.3
mmol/l
1.1
1.3
2.40
385
1378
(3014576) Chloride [Moles/volume] in Serum or Plasma
487
2020
2.76
78.69
7.9
5.4
mmol/l
104.1
103.9
0.44
479
1976
(3036489) Thrombin time
240
658
3.94
76.81
1.8
1.8
s
21.2
20.8
0.54
232
559
(3003694) ABO and Rh group [Type] in Blood
854
4665
2.28
75.55
1.4
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
581
2704
2.51
73.78
2.3
1.9
s
28.8
29.3
1.26
570
2611
(3012441) Differential panel - Pleural fluid
85
89
9.86
73.06
1.2
1.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
358
1311
3.03
72.44
8.3
6.5
mmol/l
7.5
9.7
9.62
351
1243
(3042936) Bacteria identified in Isolate by Culture
527
2394
2.53
70.09
1.8
1.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
402
1612
2.79
68.63
4.9
3.0
u/l
253.8
237.0
1.58
388
1495
(3020630) Protein [Mass/volume] in Serum or Plasma
385
1563
2.74
63.90
6.2
1.5
g/l
64.3
66.8
8.40
365
1370
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
177
454
4.13
61.85
2.7
3.6
u/ml
0.4
0.4
0.36
86
273
(3045788) Cell count panel - Pleural fluid
77
90
8.80
60.85
1.3
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1850
21408
0.44
60.73
4.3
5.3
mmol/l
2.9
2.8
1.68
1638
19598
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
55
39
14.41
60.55
2.0
3.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1640
19795
0.48
59.39
5.1
5.9
mmol/mol
39.8
39.6
0.15
1473
18232
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1341
9293
1.99
58.53
6.1
4.7
mmol/l
1.2
1.2
49.56
1261
8153
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1808
20989
0.46
54.98
3.9
4.7
mmol/l
4.9
4.9
0.98
1609
19318
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1791
20844
0.47
54.16
3.9
4.6
mmol/l
1.6
1.6
1.35
1590
19061
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
42
23
18.56
52.62
1.2
1.2
%
67.4
54.0
0.81
37
16
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1938
15634
2.17
51.47
11.5
5.3
u/l
87.9
75.8
14.00
1860
14380
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1415
10403
1.86
47.27
6.6
5.2
mmol/l
1.2
1.2
55.40
1267
8677
(3015377) Calcium [Moles/volume] in Serum or Plasma
1040
6984
1.85
46.18
5.6
2.1
mmol/l
2.4
2.4
2.53
959
5812
(3013826) Glucose [Moles/volume] in Serum or Plasma
1539
11695
1.86
45.37
5.7
3.8
mmol/l
6.7
6.6
1.56
1471
10785
(3031040) Bacteria [#/volume] in Urine by Automated count
1778
14186
1.94
44.56
5.8
4.9
e6/l
1112.3
3174.7
1.58
41
175
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1825
20870
0.50
43.88
4.5
4.8
mmol/l
5.9
5.9
0.01
1634
18925
(3009261) Glucose [Presence] in Urine by Test strip
1429
10696
1.81
43.35
6.2
4.1
estimate
0.0
0.0
1.32
263
1805
(3026008) Bacteria identified in Urine by Culture
1094
7594
1.80
42.50
3.4
3.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1413
10603
1.79
41.85
8.7
5.5
estimate
0.0
0.0
0.80
251
1793
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1735
20098
0.53
41.55
3.6
4.1
mmol/l
1.3
1.3
1.61
1526
18176
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
960
6510
1.78
39.56
3.6
2.2
u/l
56.1
57.6
0.41
906
5892
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
27
10
27.29
39.29
1.1
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
921
6180
1.79
39.28
7.0
2.5
u/l
33.6
29.5
0.66
881
5811
(3035880) pH of Pleural fluid
45
46
9.95
39.25
1.1
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
168
571
3.09
38.01
1.9
1.8
ug/l
2.0
1.2
0.62
161
478
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
142
445
3.33
36.76
1.4
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1788
20371
0.54
36.12
5.4
5.5
mu/l
2.1
2.0
0.59
1620
18652
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
35
31
11.44
33.60
11.1
1.0
u/l
48.2
43.9
0.12
26
12
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
85
198
4.41
33.60
3.1
1.4
nmol/l
0.2
0.3
3.86
62
156
(3018095) Leukocytes [#/volume] in Urine
979
6929
1.69
32.94
5.4
3.6
e6/l
94.9
120.4
0.50
654
4620
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
278
1303
2.28
32.79
1.5
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
378
2061
1.99
29.92
2.7
2.1
umol/l
6.5
6.1
0.14
321
1716
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
45
65
7.03
29.71
1.6
1.3
ug/l
18.5
15.0
1.49
45
65
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
127
431
3.05
28.76
2.0
2.0
u/l
121.2
2599.6
3.41
45
193
(3002582) Erythrocytes [#/volume] in Urine
809
5631
1.65
27.86
3.1
3.1
e6/l
49.1
58.4
0.28
605
4169
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
478
2889
1.81
27.36
1.7
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
752
5199
1.65
26.28
6.5
4.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
216
998
2.28
26.19
1.7
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
378
6098
0.55
24.76
1.6
1.6
mmol/l
1.5
1.3
2.74
332
5084
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
180
813
2.31
22.98
8.9
8.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1552
17847
0.64
22.93
4.6
4.5
pmol/l
15.1
14.9
2.98
1395
16209
(3003458) Phosphate [Moles/volume] in Serum or Plasma
380
2251
1.82
22.91
4.7
4.4
mmol/l
1.0
1.0
0.81
352
2031
(36304419) Bacteria [Presence] in Urine
729
5143
1.60
22.82
3.0
2.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
83
253
3.36
22.47
1.2
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
740
5264
1.58
22.25
3.1
3.0
e6/l
0.6
0.4
0.65
541
3876
(3035350) Ketones [Presence] in Urine by Test strip
1304
10516
1.52
21.94
6.5
4.1
estimate
0.0
0.0
0.00
254
1795
(40761535) Cells panel - Urine sediment
316
1826
1.84
20.52
4.7
3.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
305
1744
1.86
20.49
2.1
2.1
u/l
31.5
34.8
0.85
263
1473
(40768793) Breast Pathology biopsy report
72
213
3.45
20.45
1.4
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
388
2402
1.73
19.91
2.3
2.5
%
21.2
21.9
0.52
329
1985
(3018418) pH of Serum or Plasma
826
6148
1.52
19.74
3.4
3.2
ph
7.4
7.4
0.04
112
1044
(3007853) Bacteria identified in Skin by Aerobe culture
351
2119
1.77
19.66
1.5
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1697
14662
1.52
19.12
7.5
4.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
335
2017
1.77
18.90
1.7
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
764
5647
1.51
18.64
6.3
4.7
estimate
0.0
0.0
0.32
248
1828
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
484
3235
1.62
18.40
2.8
2.5
e6/l
1.9
1.5
0.56
255
1805
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
331
2021
1.74
17.72
1.7
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
202
1057
1.99
17.64
1.5
1.7
—
—
—
0
0
(3039000) Anion gap in Blood
99
387
2.62
17.29
5.2
7.3
mmol/l
11.2
10.9
0.43
88
341
(3018572) Chloride [Moles/volume] in Blood
99
387
2.62
17.29
5.2
7.3
mmol/l
104.6
104.4
0.15
88
341
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
642
4647
1.52
17.02
1.8
1.7
mg/l
2.1
1.1
8.73
545
3523
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
115
487
2.43
16.99
2.1
3.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
435
2884
1.62
16.96
2.9
2.7
e6/l
4.5
4.8
0.17
214
1463
(3009214) Lutropin [Units/volume] in Serum or Plasma
67
215
3.18
16.76
1.9
1.3
u/l
21.5
18.0
0.88
61
164
(3002032) Base excess in Venous blood by calculation
270
1595
1.78
16.15
3.5
3.3
mmol/l
2.5
2.1
0.83
226
1343
(3004789) Transferrin [Mass/volume] in Serum or Plasma
399
2629
1.62
15.88
2.3
2.4
g/l
2.2
2.4
9.44
378
2407
(3004809) Band form neutrophils/100 leukocytes in Blood
63
202
3.18
15.79
2.8
3.2
%
1.7
1.2
0.61
53
149
(3027945) Reticulocytes/100 erythrocytes in Blood
304
1871
1.71
15.73
2.1
2.3
%
2.0
1.8
1.86
284
1615
(3022948) Iron [Moles/volume] in Serum or Plasma
433
2932
1.58
15.32
2.3
2.4
umol/l
12.6
13.0
0.43
418
2677
(3021447) Carbon dioxide [Partial pressure] in Venous blood
268
1604
1.75
15.30
3.5
3.3
kpa
5.8
5.8
0.22
262
1567
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
780
9824
0.70
14.81
2.2
2.3
nmol/l
77.6
80.7
2.39
705
8671
(3008757) Leukocyte morphology finding [Identifier] in Blood
49
141
3.53
14.58
2.8
3.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
555
4023
1.49
14.24
2.5
2.5
e6/l
8.1
7.4
0.40
491
3458
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
412
2809
1.56
14.05
9.9
6.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
381
2572
1.57
13.54
13.6
25.5
inr
1.2
1.3
0.28
42
373
(1761868) Lipid panel - Serum or Plasma
508
6828
0.68
13.36
2.7
3.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
126
618
2.10
13.14
6.5
2.3
g/l
0.1
0.3
5.12
73
164
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
83
347
2.44
12.67
1.1
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1221
10323
1.37
12.67
7.0
5.6
e9/l
0.2
0.2
9.13
1047
8970
(3012544) pH of Venous blood
265
1664
1.66
12.63
3.4
3.3
—
7.4
—
0
7
(3001604) Monocytes [#/volume] in Blood
1176
9895
1.36
12.52
6.8
5.4
e9/l
0.6
0.6
0.24
995
8448
(3019198) Lymphocytes [#/volume] in Blood
1205
10190
1.36
12.37
6.8
5.5
e9/l
1.8
1.9
0.32
1036
8882
(3030981) Hyaline casts [#/volume] in Urine by Automated count
162
889
1.88
12.28
2.4
2.5
e6/l
0.3
0.3
0.01
155
854
(3006315) Basophils [#/volume] in Blood
1179
9952
1.36
12.17
6.8
5.5
e9/l
0.0
0.0
2.56
994
8491
(3023520) Reticulocytes [#/volume] in Blood
226
1382
1.70
11.89
2.0
2.3
e9/l
72.5
71.5
0.10
133
1032
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
21
36
5.88
11.79
2.6
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
114
564
2.07
11.65
5.3
6.2
mmol/l
1.3
1.2
0.43
99
490
(3024354) Oxygen [Partial pressure] in Venous blood
221
1353
1.70
11.58
3.4
2.7
kpa
4.3
4.5
0.67
215
1318
(3019069) Monocytes/100 leukocytes in Blood
1097
9207
1.35
11.52
6.7
5.9
%
8.6
8.4
0.93
1026
8480
(3000963) Hemoglobin [Mass/volume] in Blood
2207
22943
0.60
11.46
41.4
18.3
g/l
122.3
132.5
209.47
2178
22559
(3010813) Leukocytes [#/volume] in Blood
2207
22939
0.60
11.34
41.1
18.2
e9/l
6.7
6.5
2.00
2139
22168
(3026361) Erythrocytes [#/volume] in Blood
2207
22936
0.60
11.25
41.1
18.2
e12/l
4.1
4.4
126.74
2141
22170
(3035941) MCH [Entitic mass]
2207
22935
0.60
11.22
40.9
18.1
pg
30.2
30.2
0.05
2177
22547
(3024731) MCV [Entitic volume]
2207
22932
0.60
11.13
41.0
18.1
fl
91.7
91.1
7.48
2177
22545
(42870588) Differential panel, method unspecified - Blood
812
6536
1.36
11.09
6.5
5.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2207
22925
0.60
10.92
41.1
18.2
e9/l
273.7
261.8
10.18
2147
22248
(3002030) Lymphocytes/100 leukocytes in Blood
1115
9449
1.33
10.69
6.5
5.8
%
25.8
29.0
14.31
1041
8645
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
152
857
1.83
10.60
2.8
2.4
%
1.3
1.1
0.98
152
848
(3021589) Normoblasts [#/volume] in Blood
1047
8815
1.33
10.41
13.5
8.2
e9/l
0.0
0.0
0.66
833
7183
(3026782) Osmolality of Urine
490
3660
1.42
10.36
2.9
2.7
mosm/kgh2o
501.7
507.5
0.26
429
3045
(3017181) Myelocytes/100 leukocytes in Blood
244
1584
1.60
10.14
3.3
3.7
%
1.4
0.7
3.62
121
286
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
243
1581
1.60
10.01
5.5
2.3
ml/min/173m2
59.3
65.2
1.97
124
634
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
125
677
1.89
9.91
1.6
1.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
39
125
3.15
9.89
1.7
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
1074
9159
1.31
9.42
6.5
5.6
%
2.3
2.9
17.94
1000
8384
(3013707) Erythrocyte sedimentation rate by Westergren method
1466
16198
0.76
9.37
3.6
4.4
mm/h
17.1
12.7
15.71
1334
14909
(3022096) Basophils/100 leukocytes in Blood
1044
8876
1.31
9.34
6.5
5.7
%
0.6
0.7
4.74
975
8128
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
127
724
1.80
8.58
1.7
1.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
16
29
5.55
8.50
1.2
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
299
4131
0.69
8.45
1.2
1.3
u/ml
14.7
13.6
0.08
117
1565
(3007930) Methemoglobin/Hemoglobin.total in Blood
131
758
1.77
8.43
4.5
5.0
%
0.9
0.9
0.07
120
708
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
317
4330
0.69
8.41
1.3
1.3
iu/ml
46.3
34.0
0.32
102
1390
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
949
8061
1.29
8.23
6.2
4.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
130
757
1.76
8.19
4.5
5.0
%
1.7
1.6
0.76
119
704
(3021879) Hepatitis B virus core Ab [Presence] in Serum
162
1007
1.65
8.04
1.2
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
175
1118
1.61
7.79
2.9
2.9
g/l
118.2
128.4
7.70
170
1085
(3018010) Neutrophils/100 leukocytes in Blood
1080
9369
1.27
7.78
6.4
5.5
%
58.9
56.7
5.21
1009
8609
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
62
289
2.18
7.50
1.7
1.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
12
19
6.34
7.24
1.6
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
128
772
1.69
7.15
3.7
3.5
mmol/l
24.8
24.4
0.51
112
696
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
69
342
2.05
7.14
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
69
342
2.05
7.14
1.2
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
590
4787
1.31
7.04
5.4
4.7
kg/l
1.0
1.0
0.64
58
732
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
14
27
5.21
6.97
6.4
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
15
32
4.71
6.69
1.4
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
269
1945
1.43
6.67
3.5
3.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
805
9332
0.79
6.43
2.0
2.0
pmol/l
93.5
99.8
3.29
443
4224
(40760892) CBC W Ordered Manual Differential panel - Blood
530
4287
1.30
6.40
5.8
4.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
229
1625
1.45
6.29
1.4
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
498
4007
1.31
6.24
3.4
2.2
mmol/l
2.5
2.5
11.72
439
3441
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
202
2846
0.68
6.22
3.9
4.8
%
31.0
33.9
3.32
127
1862
(40768441) Liver Pathology biopsy report
29
105
2.78
6.05
1.3
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
572
4716
1.28
5.90
1.3
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
12
24
5.02
5.74
1.3
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
560
6668
0.79
5.43
3.7
3.8
mg/mmol
16.0
7.5
4.22
336
3755
(3018738) Hemoglobin F/Hemoglobin.total in Blood
8
5
16.05
5.41
1.3
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
160
2294
0.68
5.40
1.7
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
31
124
2.52
5.37
1.3
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
610
5136
1.25
5.19
2.0
2.3
mg/l
3.1
3.0
0.64
523
4359
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
92
557
1.68
5.15
1.2
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
529
6303
0.79
5.10
3.1
3.1
mg/l
351.0
420.1
0.14
318
3511
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
233
1727
1.39
5.03
2.5
2.5
ug/l
3.4
6.2
5.31
203
1464
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
96
1509
0.62
5.01
2.1
2.4
au/ml
41.6
28.1
—
6
75
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
709
6103
1.23
4.87
2.9
2.9
ng/l
1255.2
1182.1
0.11
628
5170
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
898
7928
1.21
4.77
3.4
3.7
ng/l
26.5
84.7
0.90
665
5262
(40768795) Lymph node Pathology biopsy report
15
42
3.59
4.76
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
92
573
1.63
4.65
3.0
3.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
266
2039
1.34
4.65
1.4
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
87
1371
0.62
4.61
1.2
1.3
au/ml
23.3
46.7
—
5
62
(3009508) Creatinine [Moles/volume] in Urine
560
6569
0.81
4.60
3.0
3.0
mmol/l
6.2
6.2
0.09
470
5454
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
415
5033
0.79
4.60
1.2
1.3
u/ml
0.7
1.8
6.95
126
1305
(36660697) Celiac disease serology panel - Serum
127
1842
0.67
4.56
1.1
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
31
135
2.31
4.52
3.6
2.6
%
58.5
59.1
0.04
22
87
(3051651) Icteric interference index of Serum or Plasma
22
81
2.73
4.51
3.4
4.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2143
20674
1.30
4.33
21.4
12.0
mg/l
35.4
20.2
62.24
1951
15873
(3009542) Hematocrit [Volume Fraction] of Blood
1752
18429
0.82
4.28
27.1
13.5
%
36.4
38.8
22.47
1218
12506
(3014765) Yersinia sp identified in Stool by Organism specific culture
101
658
1.56
4.26
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
100
651
1.56
4.24
1.2
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
27
114
2.38
4.23
1.1
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
57
321
1.79
4.18
1.4
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
38
729
0.51
4.16
1.6
1.7
mg/l
7.9
3.6
0.48
25
518
(3022475) Manganese [Moles/volume] in Blood
9
13
6.94
4.16
1.4
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49
264
1.87
4.13
1.3
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
90
1368
0.64
4.09
1.3
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
101
665
1.54
4.08
1.1
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
203
1535
1.35
3.91
3.6
3.8
%
0.3
0.1
2.92
91
269
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
61
361
1.71
3.80
1.8
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
57
331
1.74
3.80
1.4
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
116
800
1.47
3.79
10.5
7.3
mmol/l
24.3
24.6
0.57
108
733
(3000492) Spirometry study
132
1827
0.71
3.70
1.5
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
65
397
1.65
3.62
1.3
1.3
mmol/l
59.4
61.3
0.15
49
321
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
6
6
10.02
3.50
1.7
1.3
umol/l
175.7
147.2
—
6
6
(3044889) 12 lead EKG panel
1568
14766
1.17
3.49
4.1
3.7
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
19
75
2.55
3.46
2.2
2.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
275
3389
0.79
3.43
1.4
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
129
1768
0.71
3.43
1.4
1.6
%
1.4
1.4
0.03
109
1551
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
104
1475
0.69
3.37
2.0
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
36
189
1.92
3.34
1.3
1.3
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
6
7
8.59
3.26
1.0
5.1
umol/l
50.2
391.6
—
6
7
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
41
227
1.82
3.24
1.3
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
37
201
1.85
3.12
1.4
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
106
750
1.43
3.08
1.6
1.6
g/l
1.9
1.6
1.82
84
642
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
6
8
7.52
3.05
1.2
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
347
4107
0.82
2.98
1.5
1.3
g/l
2.0
2.3
4.27
206
2272
(40761536) Microorganisms panel - Urine sediment
213
1691
1.28
2.95
8.3
4.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
70
460
1.54
2.94
1.3
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
71
1051
0.67
2.92
1.9
1.8
—
—
—
0
0
(4010399)
122
1637
0.73
2.88
1.3
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
40
231
1.74
2.80
1.4
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
67
443
1.53
2.76
2.7
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1123
12045
0.87
2.75
2.6
2.8
—
—
—
0
0
(3048879) Bone marrow aspiration report
11
37
2.98
2.69
1.5
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
16
67
2.40
2.63
1.5
2.2
e6/l
677.8
767.3
—
5
31
(3025159) Blasts/100 leukocytes in Blood
186
1476
1.28
2.61
3.7
3.8
%
0.0
0.4
0.59
72
239
(3008536) Aspergillus sp Ab [Presence] in Serum
7
15
4.68
2.59
1.1
1.5
—
—
—
0
0
(44806118)
30
163
1.85
2.57
1.6
1.3
—
—
—
0
0
(44790047)
30
163
1.85
2.57
1.6
1.3
—
—
—
0
0
(44790048)
30
163
1.85
2.57
1.6
1.3
—
—
—
0
0
(44790049)
30
163
1.85
2.57
1.6
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
25
128
1.96
2.55
3.2
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
604
6733
0.86
2.54
2.1
2.1
u/l
130.6
170.9
2.18
568
6263
(3019309) Folate [Moles/volume] in Red Blood Cells
364
4225
0.84
2.53
1.8
1.7
nmol/l
1255.9
1200.6
0.49
267
3131
(3011412) CD3 cells [#/volume] in Blood
21
101
2.09
2.53
2.0
1.9
e9/l
0.9
1.1
0.60
15
59
(3019832) Treponema pallidum Ab [Presence] in Serum
75
1063
0.70
2.49
1.5
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
69
992
0.69
2.48
1.6
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
44
694
0.63
2.47
1.0
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
19
89
2.14
2.44
1.5
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
137
1056
1.32
2.41
1.3
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
261
3110
0.82
2.40
1.4
1.3
titre
556.2
589.0
0.13
74
741
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
54
353
1.54
2.38
3.9
3.7
%
62.1
57.5
1.46
54
353
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
27
146
1.86
2.37
1.0
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2167
22108
0.82
2.37
19.6
9.2
u/l
23.1
23.0
0.12
2119
21128
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
180
1445
1.27
2.33
5.9
3.0
pmol/l
4.4
4.5
0.26
167
1259
(3003327) Ova and parasites identified in Stool by Light microscopy
45
695
0.64
2.32
1.5
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
35
572
0.61
2.31
1.3
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34
200
1.71
2.28
1.3
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
17
79
2.16
2.24
2.1
1.7
%
14.9
13.9
—
10
35
(3013139) Helicobacter pylori Ag [Presence] in Stool
130
1655
0.77
2.17
1.2
1.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
7
19
3.69
2.15
1.1
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
16
74
2.17
2.14
1.3
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
16
74
2.17
2.14
1.3
1.2
—
—
—
0
0
(1002224) Polysomnography panel
48
717
0.66
2.14
1.1
1.1
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
17
81
2.11
2.12
2.1
1.7
%
74.6
73.9
0.07
17
75
(3042631) Mycobacterium sp identified in Specimen
34
205
1.67
2.11
2.1
3.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
14
62
2.27
2.07
1.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
52
349
1.50
2.07
1.3
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
33
530
0.62
2.06
1.2
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
84
1127
0.74
2.05
1.9
1.8
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
17
83
2.06
2.01
1.1
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
17
83
2.06
2.01
1.1
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
36
224
1.62
1.99
1.1
1.3
u/ml
132.2
120.7
—
10
46
(3002385) Erythrocyte distribution width [Ratio]
1754
16927
1.13
1.97
32.1
14.5
%
14.5
13.7
69.40
1730
16510
(3048689) Calprotectin [Mass/mass] in Stool
230
2719
0.83
1.97
1.7
2.0
ug/g
134.6
122.8
0.17
176
2071
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
16
77
2.09
1.96
2.1
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
115
1464
0.77
1.94
1.3
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
26
434
0.59
1.91
1.6
1.7
mu/l
331.8
349.9
0.12
21
383
(3002179) Metamyelocytes/100 leukocytes in Blood
180
1483
1.23
1.90
3.7
3.6
%
0.9
0.5
1.43
58
218
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
51
0.00
1.88
0.0
1.9
—
9.8
—
0
41
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1340
12754
1.11
1.88
4.1
2.9
u/l
55.6
40.1
6.96
1248
11653
(40761511) CBC panel - Blood by Automated count
2106
21480
0.86
1.86
23.0
11.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
32
198
1.62
1.83
1.3
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
441
3943
1.14
1.80
3.7
3.7
ng/l
56.3
290.9
4.57
358
2994
(3045424) Erythrocytes [Presence] in Urine
54
378
1.44
1.79
2.1
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
21
116
1.82
1.78
1.1
1.2
—
—
—
0
0
(4094501)
38
570
0.66
1.78
1.1
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
6
150
0.40
1.76
1.0
2.0
—
6.0
—
0
9
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
39
256
1.53
1.76
1.1
1.3
—
12.8
—
0
6
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
31
193
1.61
1.74
1.4
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
599
5473
1.13
1.74
5.7
3.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
10
42
2.39
1.67
1.2
1.1
—
—
—
0
0
(4034850)
93
720
1.30
1.67
11.6
8.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
143
1168
1.24
1.67
1.3
1.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2167
22028
0.85
1.66
33.3
13.9
umol/l
70.2
70.4
0.11
2167
22021
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
21
119
1.77
1.66
1.1
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
8
31
2.59
1.66
1.0
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
108
1354
0.79
1.65
1.3
1.3
u/ml
226.3
181.5
0.22
97
1241
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
78
1019
0.76
1.64
1.2
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
30
189
1.59
1.63
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
10
43
2.33
1.60
1.1
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
841
8974
0.90
1.60
2.7
2.8
ug/l
182.9
92.1
12.37
787
8197
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
84
1.91
1.59
1.3
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
41
280
1.47
1.57
2.2
2.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
68
898
0.75
1.56
1.6
1.6
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
7
159
0.44
1.54
1.7
1.9
ug/l
7.0
3.9
—
7
142
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
24
145
1.66
1.54
1.5
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
18
100
1.81
1.53
1.2
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
144
0.42
1.51
1.2
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
6
144
0.42
1.51
2.3
1.4
—
612.7
—
0
15
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
144
0.42
1.51
1.2
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
61
454
1.35
1.47
4.7
3.7
mg/l
31.6
23.9
0.71
52
284
(3043410) Blood group antigens tested for on Red Blood Cells
9
38
2.37
1.45
1.2
1.4
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
5
16
3.13
1.44
2.2
1.3
u/l
214.8
3654.8
—
5
6
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
101
809
1.26
1.43
1.6
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
36
245
1.48
1.42
1.3
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
36
245
1.48
1.42
1.3
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
37
254
1.46
1.40
1.1
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
36
248
1.46
1.35
1.3
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
138
1643
0.83
1.34
1.1
1.2
iu/ml
117.1
140.0
0.31
48
643
(3051611) Lipemic interference index of Serum or Plasma
30
200
1.51
1.32
3.0
3.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
147
0.47
1.32
1.0
2.4
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
19
113
1.69
1.31
1.7
1.3
umol/l
45.8
22.6
1.70
19
106
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
18
295
0.61
1.31
1.4
1.6
%
53.9
58.7
0.21
12
184
(3040151) Glucose [Moles/volume] in Capillary blood
30
201
1.50
1.29
2.0
4.3
mmol/l
8.3
6.9
0.75
24
167
(3024980) IgG subclass 4 [Mass/volume] in Serum
19
305
0.62
1.28
1.7
1.6
g/l
1.2
0.7
0.23
13
225
(40768443) Skin Pathology biopsy report
72
913
0.78
1.27
1.2
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
36
252
1.43
1.26
1.3
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
105
1275
0.82
1.26
1.9
1.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
36
253
1.43
1.24
1.1
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
120
1001
1.21
1.21
4.0
3.4
mmol/l
2.3
2.1
0.21
94
767
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
17
276
0.61
1.21
1.3
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
278
3106
0.88
1.21
1.2
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
46
340
1.36
1.20
3.0
3.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
26
2.31
1.18
1.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
33
0.00
1.16
0.0
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
35
249
1.41
1.15
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
296
0.64
1.14
1.1
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
30
426
0.70
1.14
2.5
2.4
ug/min
342.0
68.4
0.46
15
241
(3025577) Chromium [Mass/volume] in Blood
8
153
0.52
1.14
1.6
2.0
ug/l
3.2
3.1
—
8
127
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
36
258
1.40
1.13
1.3
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
16
257
0.62
1.11
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
16
257
0.62
1.11
1.3
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
45
594
0.75
1.10
1.2
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
110
1308
0.83
1.09
2.3
2.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
16
256
0.62
1.09
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
16
256
0.62
1.09
1.3
1.4
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
123
1042
1.19
1.08
1.8
1.5
g/l
1.3
1.2
0.21
110
933
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
59
748
0.78
1.07
1.7
1.9
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
35
254
1.38
1.04
1.3
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
23
154
1.50
1.03
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
69
554
1.25
1.03
5.5
4.5
—
—
—
0
0
(3009343) pH of Capillary blood
122
1039
1.18
1.02
3.9
3.4
ph
7.4
7.4
0.12
20
135
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
47
1.92
1.02
1.2
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
47
1.92
1.02
1.2
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
47
1.92
1.02
1.3
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
98
818
1.21
1.02
1.7
1.3
iu/l
35.6
35.2
0.05
82
717
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
42
552
0.76
1.01
1.5
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
177
0.56
1.01
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
107
0.47
1.01
1.0
1.1
—
—
—
0
0
(4146454)
15
238
0.63
1.00
2.8
2.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
35
2.00
1.00
1.3
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
32
436
0.73
0.99
3.7
1.5
—
—
—
0
0
(3010421) pH of Blood
56
441
1.28
0.98
3.4
3.2
ph
7.4
7.4
0.25
42
359
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
23
2.18
0.98
1.2
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
18
272
0.66
0.97
1.2
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
22
319
0.69
0.97
1.1
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
19
124
1.54
0.96
1.4
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
19
124
1.54
0.96
1.4
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
19
124
1.54
0.96
1.4
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
17
259
0.65
0.96
1.1
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
735
0.80
0.95
2.3
1.4
g/l
9.2
10.1
1.18
50
591
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
39
294
1.33
0.94
1.5
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
172
0.58
0.93
1.2
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
786
0.81
0.92
2.9
1.4
g/l
7.4
7.6
0.60
47
559
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
49
620
0.79
0.91
2.7
1.4
g/l
36.3
37.7
0.94
43
505
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
785
0.81
0.91
2.9
1.4
g/l
3.5
3.8
1.49
47
535
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
17
110
1.55
0.90
1.3
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
784
0.81
0.90
2.9
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
42
539
0.78
0.88
1.4
1.6
e6/l
16287.1
10167.2
0.55
34
390
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
106
906
1.18
0.88
1.3
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
21
299
0.70
0.86
1.4
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
32
425
0.75
0.86
1.8
2.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
8
44
1.82
0.85
1.1
1.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
149
1311
1.15
0.85
2.7
2.5
g/l
9.7
10.5
1.25
137
1190
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
13
204
0.64
0.85
1.5
1.5
%
40.6
36.9
—
8
120
(3004616) Nuclear Ab [Presence] in Serum
22
310
0.71
0.85
1.5
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
55
443
1.25
0.83
1.1
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
46
1.74
0.82
1.0
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
166
1861
0.88
0.81
3.2
3.2
ng/l
79.7
82.5
0.17
144
1549
(3021788) Differential panel - Synovial fluid
31
408
0.76
0.80
1.3
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
51
630
0.81
0.80
1.3
1.6
iu/ml
0.0
0.1
0.53
16
132
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
2.1
—
21.5
—
0
24
(3019174) dRVVT (LA screen)
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
33
1.82
0.79
3.2
1.8
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
25
0.00
0.79
0.0
8.3
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.2
—
0.0
—
0
12
(3026389) Candida sp identified in Specimen by Organism specific culture
44
348
1.27
0.79
1.4
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
85
997
0.85
0.78
1.2
1.3
u/ml
0.5
1.0
—
8
99
(3028300) Cannabinoids [Presence] in Urine
26
350
0.74
0.78
1.1
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
19
131
1.45
0.78
1.5
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
61
737
0.82
0.78
3.0
1.4
g/l
3.2
3.1
0.25
47
548
(3027456) Digoxin [Moles/volume] in Serum or Plasma
60
493
1.22
0.78
2.5
3.3
nmol/l
0.7
0.8
2.10
47
390
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
99
0.50
0.77
1.8
2.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
53
649
0.81
0.77
3.4
1.4
g/l
0.7
0.3
0.60
47
542
(3000570) Elastase.pancreatic [Mass/mass] in Stool
54
659
0.82
0.76
1.5
1.4
ug/g
253.4
300.0
1.25
33
380
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
34
1.77
0.76
1.3
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
26
348
0.74
0.76
1.1
1.4
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.1
—
10.3
—
0
6
(3004588) Protein electrophoresis panel - Serum or Plasma
122
1387
0.87
0.75
2.2
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
21
149
1.41
0.75
1.5
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
18
124
1.45
0.75
1.0
1.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
49
602
0.81
0.74
1.1
1.1
u/ml
2.5
8.2
—
9
60
(3027008) Opiates [Presence] in Urine
26
346
0.75
0.74
1.1
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
21
289
0.72
0.73
1.4
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
26
345
0.75
0.72
1.1
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
25
2.00
0.72
1.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
13
84
1.55
0.72
1.5
1.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
57
1.58
0.71
1.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
26
1.92
0.70
1.0
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
12
182
0.66
0.70
2.5
2.5
u/field
3.0
2.4
—
6
68
(3008401) Mugwort IgE Ab [Units/volume] in Serum
18
252
0.71
0.70
1.0
1.1
u/ml
0.5
0.9
—
5
111
(21494814) CD8 cells/100 lymphocytes in Specimen
7
41
1.71
0.70
2.9
1.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
29
222
1.31
0.68
2.1
2.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
15
215
0.70
0.67
1.3
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
53
439
1.21
0.66
1.2
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31
241
1.29
0.66
1.1
1.2
u/ml
259.9
268.4
0.05
21
152
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
155
0.64
0.65
1.1
1.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
33
259
1.28
0.65
1.1
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
24
316
0.76
0.65
1.0
1.1
u/ml
0.7
1.3
—
6
120
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
37
296
1.25
0.63
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
38
468
0.81
0.62
1.3
1.5
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
14
199
0.70
0.61
1.3
1.5
g/l
4.9
6.8
—
8
135
(3024139) IgG subclass 3 [Mass/volume] in Serum
14
199
0.70
0.61
1.3
1.5
g/l
0.5
0.4
—
8
136
(3028192) IgG subclass 2 [Mass/volume] in Serum
14
199
0.70
0.61
1.3
1.5
g/l
2.3
2.7
—
8
135
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(4062490)
14
198
0.71
0.60
1.3
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
15
209
0.72
0.59
1.3
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
52
1.54
0.59
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
64
1.56
0.58
1.2
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
64
1.56
0.58
1.2
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
64
1.56
0.58
1.2
1.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
64
1.56
0.58
1.2
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
53
1.51
0.58
2.3
2.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
53
1.51
0.58
2.3
2.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
30
237
1.27
0.58
2.6
2.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
15
208
0.72
0.58
1.3
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
20
149
1.35
0.57
2.0
2.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
161
0.68
0.57
3.5
3.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
36
1.67
0.56
1.3
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
42
347
1.21
0.56
1.3
2.9
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
37
1.62
0.55
1.5
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
15
205
0.73
0.54
1.2
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
16
216
0.74
0.53
1.3
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
50
423
1.19
0.53
1.9
2.1
g/l
120.2
127.8
1.68
45
304
(3019977) pH of Arterial blood
13
91
1.43
0.53
1.8
2.4
ph
7.4
7.4
—
5
29
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
21
271
0.77
0.52
1.0
1.1
u/ml
1.8
2.8
—
10
109
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
96
0.62
0.52
1.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
97
0.62
0.52
1.0
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
18
237
0.76
0.52
1.0
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
158
1449
1.10
0.51
7.0
2.7
e9/l
4.3
4.0
0.50
136
1086
(40767503) Oxygen content in Capillary blood by calculation
42
351
1.20
0.51
2.1
2.5
%
14.9
16.3
1.54
27
180
(3003888) Timothy IgE Ab [Units/volume] in Serum
20
259
0.77
0.51
1.0
1.1
u/ml
2.9
2.4
—
7
130
(3034860) Kappa light chains.free [Mass/volume] in Serum
51
595
0.85
0.50
3.1
1.5
mg/l
52.4
38.6
0.56
44
482
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
51
595
0.85
0.50
3.1
1.5
mg/l
27.6
38.8
0.56
45
478
(3025130) Human papilloma virus identified in Specimen
40
334
1.20
0.50
1.6
1.7
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
61
529
1.16
0.49
1.1
1.2
titre
68.3
95.1
—
6
39
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
12
84
1.43
0.49
1.2
1.5
umol/l
2.8
3.9
0.73
12
78
(3020961) Endomysium IgA Ab [Titer] in Serum
92
1027
0.89
0.49
1.1
1.1
titre
—
188.8
—
0
28
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
25
312
0.80
0.48
1.2
1.3
nmol/l
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
20
154
1.30
0.48
1.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
18
137
1.32
0.47
1.1
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
43
365
1.18
0.46
3.3
3.4
mmol/l
3.4
2.6
1.01
29
257
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
18
232
0.77
0.46
1.0
1.0
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
22
174
1.27
0.45
2.0
1.8
umol/l
5.2
8.1
0.81
16
115
(3002523) Influenza virus A Ag [Presence] in Specimen
18
231
0.78
0.44
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
51
1.37
0.44
1.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
51
1.37
0.44
1.6
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
45
386
1.17
0.43
6.0
3.0
mg/l
1.6
1.6
0.06
45
346
(3003740) Influenza virus B Ag [Presence] in Specimen
18
230
0.78
0.43
1.1
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
127
0.71
0.43
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
29
350
0.83
0.43
1.2
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
56
1.43
0.42
2.4
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
30
249
1.21
0.41
1.4
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
33
1.52
0.41
1.4
2.4
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(4212803)
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
16
123
1.30
0.40
1.1
1.1
ratio
1.1
1.0
—
7
43
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
18
0.00
0.40
0.0
2.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
28
232
1.21
0.40
1.2
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
158
1695
0.93
0.39
3.2
2.8
mmol/l
1.2
1.2
0.48
141
1394
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
57
504
1.13
0.38
1.2
1.3
miu/ml
265.9
230.4
0.23
20
252
(3028433) Virus identified in Specimen by Culture
9
66
1.36
0.38
1.1
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
36
1.39
0.38
1.8
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
13
170
0.76
0.38
1.0
1.2
u/ml
2.5
1.6
—
8
69
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
68
1.32
0.37
1.4
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
68
1.32
0.37
1.4
1.4
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
5
37
1.35
0.37
1.0
1.1
—
86.3
—
0
7
(3004775) Volume in Urine collected for unspecified duration
10
135
0.74
0.36
2.1
2.5
ml
483.4
610.2
—
5
95
(3045414) Leukocytes [Presence] in Urine
114
1053
1.09
0.36
2.6
2.0
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
76
0.66
0.35
7.0
2.5
umol/l
33.4
28.4
—
5
57
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
79
0.63
0.35
3.0
2.6
—
34.0
—
0
5
(4024509)
22
266
0.83
0.35
1.5
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
12
156
0.77
0.34
1.3
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
512
4963
1.04
0.33
2.7
2.1
umol/l
4263.7
5663.5
0.34
454
4173
(3051593) INR in Capillary blood by Coagulation assay
6
88
0.68
0.33
21.5
11.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1741
17236
1.04
0.32
36.7
16.1
g/l
328.6
330.5
18.56
1723
17113
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
51
571
0.89
0.32
3.1
1.5
ratio
1.3
1.5
—
5
61
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
10
74
1.35
0.32
1.2
1.2
g/l
0.3
0.3
—
10
57
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
12
92
1.31
0.31
1.6
2.1
%
90.8
100.0
0.47
12
82
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
52
1.35
0.31
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
7
99
0.71
0.30
1.1
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
74
677
1.10
0.30
5.0
3.5
mmol/l
25.3
25.2
0.11
69
617
(3019550) Sodium [Moles/volume] in Serum or Plasma
2179
21676
1.05
0.30
29.1
14.1
mmol/l
138.9
139.8
40.86
2142
21069
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
93
1.29
0.30
1.1
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
8
106
0.75
0.29
1.4
1.2
—
7.8
—
0
12
(3024263) Appearance of Synovial fluid
8
109
0.73
0.29
1.4
1.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
30
260
1.16
0.28
2.7
2.1
mg/l
16.9
26.5
—
10
64
(46235355) HIV 1 and 2 tests - Meaningful Use set
240
2297
1.05
0.28
1.5
1.7
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
8
64
1.25
0.27
1.0
1.2
%
—
31.8
—
0
6
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
64
698
0.91
0.27
1.3
1.3
u/ml
5.8
47.9
—
6
50
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
86
1.28
0.26
1.2
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
71
0.70
0.26
1.2
1.2
—
—
—
0
0
(4268621)
23
197
1.17
0.25
2.4
2.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
12
149
0.80
0.25
1.2
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
74
1.22
0.25
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
33
292
1.13
0.25
1.2
1.2
u/ml
3.8
4.2
0.09
11
113
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
70
647
1.08
0.24
1.4
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
19
161
1.18
0.24
1.1
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
34
303
1.12
0.23
1.2
1.3
u/ml
13.6
46.2
—
5
24
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
12
147
0.82
0.23
1.0
1.2
mmol/l
2.0
2.1
0.16
12
139
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
26
296
0.88
0.23
1.0
1.3
pmol/l
736.3
297.9
0.40
20
221
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
40
361
1.11
0.23
1.3
1.3
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
5
39
1.28
0.23
1.0
1.1
—
83.1
—
0
7
(3011648) Oxygen content in Venous blood
16
134
1.20
0.23
1.3
2.1
%
10.1
11.2
0.48
16
134
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
113
1194
0.94
0.22
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
18
153
1.18
0.22
1.7
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
33
295
1.12
0.22
1.1
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
41
1.22
0.22
1.2
1.9
mmol/l
1.2
1.2
—
5
41
(3013512) EKG study
619
6311
0.97
0.21
4.3
3.9
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
10
0.00
0.21
0.0
1.3
—
2.3
—
0
10
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
49
532
0.92
0.20
2.4
2.2
mg/l
9.7
11.4
1.14
44
483
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2181
21728
1.04
0.20
28.8
14.3
mmol/l
3.9
3.9
1.41
2143
21079
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
114
0.79
0.20
1.2
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
115
0.78
0.20
2.3
3.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
51
1.18
0.19
3.0
2.9
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
59
633
0.93
0.19
1.3
1.3
u/ml
1.3
6.5
—
7
76
(3022621) pH of Urine by Test strip
143
1491
0.96
0.18
3.2
3.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
53
1.13
0.18
1.2
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
53
1.13
0.18
1.0
1.2
—
—
—
0
0
(4027681)
12
100
1.20
0.18
1.1
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
37
404
0.91
0.18
1.1
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
30
331
0.91
0.17
1.2
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
33
362
0.91
0.17
1.1
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
60
640
0.94
0.17
1.3
1.3
u/ml
6.5
5.6
0.08
12
129
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
110
1.18
0.17
1.2
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
52
557
0.93
0.17
3.2
2.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
192
1859
1.04
0.16
3.2
1.8
nmol/l
446.7
370.0
4.08
182
1664
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
8
69
1.16
0.16
1.1
1.2
%
106.9
114.5
—
8
59
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
78
0.77
0.15
1.2
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
78
1.15
0.15
1.0
1.1
miu/ml
2509.6
1703.3
—
9
78
(3017569) Oxygen content in Arterial blood
9
79
1.14
0.15
1.3
2.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
86
0.81
0.14
1.1
1.1
—
—
—
0
0
(4306422)
31
285
1.09
0.14
1.2
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
37
398
0.93
0.14
1.1
1.3
—
88.6
—
0
7
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
32
295
1.09
0.14
1.2
1.2
u/ml
5.7
3.0
0.26
11
87
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
33
355
0.93
0.12
1.2
1.3
nmol/l
0.6
3.9
0.50
33
340
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
85
1.18
0.12
1.4
1.4
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
22
241
0.91
0.12
1.5
1.5
—
19.6
—
0
11
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
14
124
1.13
0.11
1.4
1.2
u/l
19.5
16.1
0.21
14
104
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
30
279
1.08
0.11
1.1
1.1
%
137.0
121.3
1.10
25
252
(44813793)
17
153
1.11
0.11
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
86
1.16
0.11
1.1
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
60
628
0.95
0.11
1.9
1.9
iu/l
4.9
4.9
0.03
20
218
(3022313) Gas panel - Capillary blood
78
751
1.04
0.10
4.9
3.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
96
1.15
0.10
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
238
2336
1.02
0.10
1.4
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
44
1.14
0.10
1.2
1.9
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
15
135
1.11
0.09
1.2
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
87
1.15
0.09
1.1
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
11
97
1.13
0.09
1.0
1.0
u/ml
0.6
0.4
—
5
35
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
15
165
0.91
0.09
1.2
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
56
1.07
0.08
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
56
1.07
0.08
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
56
1.07
0.08
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
56
1.07
0.08
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
36
341
1.06
0.08
1.7
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
229
2253
1.02
0.08
1.3
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
496
4911
1.01
0.08
1.5
1.7
pmol/l
18582438.3
37362539.9
0.44
409
3988
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
117
1.11
0.08
2.3
2.5
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
15
164
0.91
0.08
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
15
164
0.91
0.08
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
15
164
0.91
0.08
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
15
164
0.91
0.08
1.2
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
34
358
0.95
0.08
1.2
1.3
nmol/l
—
0.3
—
0
22
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
82
844
0.97
0.07
2.1
2.0
u/l
40.0
39.6
0.08
69
738
(3008295) Osmolality of Serum or Plasma
23
215
1.07
0.07
1.0
1.4
mosm/kgh2o
271.5
274.5
0.29
15
168
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
19
176
1.08
0.07
1.2
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
18
194
0.93
0.07
1.6
1.7
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
7
83
0.84
0.07
2.4
2.1
—
109.6
—
0
14
(40759836) Histone Ab [Presence] in Serum by Immunoblot
15
163
0.92
0.07
1.2
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
8
90
0.89
0.06
1.3
1.8
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
10
111
0.90
0.06
1.4
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
27
283
0.95
0.05
1.1
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
161
0.93
0.05
1.1
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
515
5117
1.01
0.05
1.6
1.5
nmol/l
20.1
22.0
2.13
468
4287
(3000330) Specific gravity of Urine by Test strip
115
1168
0.98
0.04
6.6
3.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
22
231
0.95
0.04
1.5
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
170
0.94
0.04
1.5
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
18
190
0.95
0.04
1.1
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
14
149
0.94
0.03
1.0
2.3
mmol/l
6.5
6.7
—
9
97
(3037756) Immunofixation for Serum or Plasma
35
360
0.97
0.03
1.5
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
51
520
0.98
0.02
1.2
1.2
u/ml
60.2
44.1
—
7
72
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
179
1802
0.99
0.02
2.6
2.9
ng/l
121.6
177.1
3.72
162
1645
(3006653) Thiamine [Moles/volume] in Blood
10
93
1.08
0.02
1.3
1.3
nmol/l
127.2
130.5
—
10
93
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
53
521
1.02
0.02
1.1
1.6
—
29.2
—
0
16
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
107
0.93
0.02
1.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
215
2158
1.00
0.01
3.5
3.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1959
19583
1.00
0.00
25.6
11.0
ml/min/173m2
79.2
77.7
2.50
1688
15591
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
109
1.01
0.00
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
19
191
0.99
0.00
1.3
1.5
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
28
281
1.00
0.00
1.6
1.8
mmol/l
1.8
1.6
0.39
28
274
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
44
439
1.00
0.00
1.2
1.3
e6/l
2.3
21.9
1.89
32
341
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
44
441
1.00
0.00
1.3
1.4
e6/l
449.3
1720.3
1.07
35
363
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
10
96
1.04
0.00
1.0
1.2
%
—
49.8
—
0
9
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
102
0.98
0.00
1.1
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
108
1.02
0.00
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
10
103
0.97
0.00
2.5
3.6
—
—
—
0
0
(4211845)
11
113
0.97
0.00
2.4
3.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
18
183
0.98
0.00
1.1
1.5
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
4.5
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
79
1.01
0.00
3.4
5.4
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
79
1.01
0.00
1.5
1.2
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
16.6
—
0
6
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
4.5
—
362.2
—
0
6
(3006567) Chloride [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
53
0.94
0.00
1.2
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
5
59
0.85
0.00
2.4
2.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
73
0.96
0.00
1.4
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
80
1.00
0.00
1.3
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
53
0.94
0.00
1.2
1.4
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763791) Oxygen content in Venous blood by calculation
0
5
0.00
0.00
0.0
2.8
—
10.5
—
0
5
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.9
—
18.1
—
0
8
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
6
64
0.94
0.00
32.8
24.4
ug/l
138.7
99.4
—
6
50
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
89
1.01
0.00
2.3
2.7
u/ml
1214.3
830.8
—
9
89
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
831.6
—
0
5
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.6
—
241.3
—
0
9
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
2.7
—
3.0
—
0
9
(4015189)
5
59
0.85
0.00
1.6
3.1
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
40
400
1.00
0.00
1.1
1.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_OVARY_EXALLC – Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)
GWS hits: 2
This endpoint is excluded (different definition than used in FinnGen).